SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-19-001476
Filing Date
2019-12-20
Accepted
2019-12-20 17:21:43
Documents
13
Period of Report
2019-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm   iXBRL 8-K 32851
2 ex99-1.htm EX-99.1 121567
  Complete submission text file 0000950157-19-001476.txt   319650

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akrx-20191216.xsd EX-101.SCH 4377
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20191216_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20191216_pre.xml EX-101.PRE 16824
9 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4058
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 191302688
SIC: 2834 Pharmaceutical Preparations